#United States #Nashville #Nuance Medical #Lidocaine #HurriCaine ONE

Introduction

Nuance Medical, known for its dedication to innovative solutions in topical anesthetics, has recently launched a groundbreaking product, HurriCaine ONE Lidocaine, which debuted at the APIC 2026 Annual Conference and Expo in Nashville, Tennessee. This new anesthetic is designed to provide rapid pain relief while adhering to the highest infection prevention standards, addressing two critical needs in modern medical environments.

The Need for Innovation in Healthcare

In today's healthcare landscape, infection control remains paramount, especially as facilities face persistent issues concerning patient safety and contamination risks. Traditional multi-use topical anesthetics often pose threats of cross-contamination, which can endanger patients. Recognizing this, Nuance Medical has developed HurriCaine ONE as a response to the demand for single-use solutions that uphold safety without compromising efficacy.

Features of HurriCaine ONE

HurriCaine ONE Lidocaine stands apart with its unique formulation and several key features:
1. Infection Control by Design: Each unit is packaged for single-patient use, drastically reducing the risk of cross-contamination that is often associated with reusable creams and gels.
2. Quality and Safety Assurance: This product has undergone rigorous testing to ensure it adds no additional bioburden and complies fully with FDA antiseptic performance standards.
3. CHG Compatibility: HurriCaine ONE integrates seamlessly into existing protocols for skin preparation and infection prevention, making it a versatile tool for healthcare providers.
4. Rapid Onset of Action: One of the most significant advantages of HurriCaine ONE is its ability to deliver pain relief within just five minutes, thus enhancing patient comfort and procedural efficiency.
5. Non-Aerosol Spray Application: The non-aerosol design allows for precise application, enabling practitioners to target the area accurately, which is especially beneficial in various medical procedures.

Applications of HurriCaine ONE

HurriCaine ONE is ideal for a variety of medical procedures including, but not limited to:

• - Venipuncture and Blood Draws: Facilitating smoother, faster access to veins while minimizing discomfort.
• - Vaccinations: Providing immediate pain relief to improve the vaccination experience.
• - IV Starts and Port Access: Offering significant relief prior to IV placements, thereby aiding in patient comfort and cooperation.
• - Minor External Procedures: Such as treating cuts, scrapes, and burns where quick pain management is necessary.
• - Pre-Injection Pain Management: Enhancing the overall experience for patients undergoing injections.

Insights from Nuance Medical Leadership

Mark Steele, President of Nuance Medical, stated, “Topical lidocaine shouldn’t come at the cost of infection control. With HurriCaine ONE Lidocaine, we can provide both. We are excited to launch it at APIC and demonstrate its capabilities to healthcare professionals.”

Conclusion

The launch of HurriCaine ONE Lidocaine marks a significant advancement in the field of topical anesthetics. By prioritizing both speed of action and infection control, Nuance Medical is setting a new standard for patient care solutions. Attendees at the APIC 2026 are encouraged to visit Booth #2225 for live demonstrations and further information on how HurriCaine ONE can enhance their clinical practices. For additional details, visit Nuance Medical’s website.

This innovative product underscores Nuance Medical's commitment to improving healthcare through safe, effective, and user-friendly solutions, ultimately leading to better patient outcomes and experiences in medical settings.